India's Generic-Drug Industry Can Take Heart With Obama Re-Election
This article was originally published in PharmAsia News
Executive Summary
India drug makers see good news in the U.S. re-election of President Obama as an affirmation of a health-care reform plan that places an emphasis on prescriptions for generic versions of drugs, an Indian specialty.